Document:

EXCLUSIVE
AGENCY AGREEMENT

 

This
EXCLUSIVE AGENCY AGREEMENT is made and entered into this 31st day of October, 2016 by and among Immune Therapeutics, Inc., a Florida
corporation (“IMUN”), its wholly owned subsidiary, TNI BioTech International, Ltd., a BVI company (collectively
with IMUN, the “Company”), and GB Pharma Holdings, LLC, a Delaware limited liability company (“Agent”).
The Company and Agent are each referred to herein as a “Party” and collectively as the “Parties.”

 

WHEREAS,
the Company is a biopharmaceutical company focused on developing and commercializing therapeutics to treat cancer, HIV/AIDS and
autoimmune diseases by combating these fatal diseases through the activation and mobilization of the body’s immune system;

 

WHEREAS,
Agent is dedicated to helping alleviate health security challenges through the implementation of initiatives that provide access
to sustainable affordable health care in Africa;

 

WHEREAS,
GB Pharma Holdings, Inc., a Colorado corporation and wholly owned subsidiary of Agent (“GBPH”), and Airmed
Biopharma Limited, an Irish company and wholly owned subsidiary of IMUN (“Airmed”), entered into that certain
Exclusive Agency Agreement (the “Original Agency Agreement”) dated June 12, 2014 pursuant to which Airmed appointed
GBPH as its exclusive agent to market and promote certain products in a specified territory; and

 

WHEREAS,
the Parties have jointly agreed to amend, revise and further define the terms and conditions set forth in the Original Agency
Agreement by replacing the Original Agency Agreement with this Agreement, which appoints Agent to act as the Company’s exclusive
agent in accordance with the terms and conditions set forth hereunder.

 

NOW,
THEREFORE, in consideration of the mutual covenants and agreements set forth below and other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, the Company and Agent agree as follows:

 

	1.
	Definitions.
                In this Agreement, the following terms shall have the meanings set forth below:

 

(a)        “Agreement”
means this Exclusive Agency Agreement and the Exhibits attached hereto and incorporated herein by this reference.

 

(b)        “Confidential
Information” shall be defined as any nonpublic information disclosed by the Company to Agent and shall be deemed to
include the following information of the Company, without limitation: (i) e-mail addresses, customer lists, the names of customer
contacts, the names of investor contacts, investor lists, professional contacts, business plans, technical data, product ideas,
personnel, contracts and financial information; (ii) patents, trade secrets, techniques, processes, business methodologies, schematics,
employee suggestions, development tools and processes, computer printouts, computer programs, design drawings and manuals, and
improvements; (iii) information about costs, profits, markets and sales; (iv) plans for future development and new product concepts;
(v) all documents, books, papers, drawings, models, sketches, and other data of any kind and description, including electronic
data recorded or retrieved by any means, that have been or will be disclosed, as well as written or oral instructions or comments.
Notwithstanding the foregoing, Confidential Information shall not include information that (i) has become public knowledge through
legal means without fault by Agent, (ii) is already public knowledge prior to the disclosure of the Confidential Information by
the Company to Agent, (iii) is known to Agent without an obligation to keep it confidential prior to the Company’s disclosure
of the same pursuant to this Agreement, or (iv) is independently developed by Agent without reference to or use of the Confidential
Information.

 

    	1

    	 

    

 

(c)        “Effective
Date” means the date first written above.

 

(d)        “Fiscal
Quarter” means the respective periods of three (3) consecutive calendar months ending on March 31, June 30, September
30 and December 31.

 

(e)        “Gross
Revenues” means any and all funds received by the Company from the sale of the Products in the Territory.

 

(f)        “Products”
means the Company’s products listed in Exhibit A.

 

(g)        “Term”
means the period commencing on the Effective Date and terminating as set forth in Section 10 of this Agreement.

 

(h)        “Territory”
means collectively the Territory Countries listed in Exhibit B and the Territory Organizations listed in Exhibit C.

 

(i)        “Territory
Countries” means the countries listed in Exhibit B.

 

(j)        “Territory
Organizations” means the organizations listed in Exhibit C.

 

(k)        “Trademarks”
means all trademarks, service marks, logos, brand names, trade names, domain names and/or slogans used by the Company in connection
with the Products from time to time (whether registered or unregistered).

 

	2.	Grant
                                         of Right.

 

(a)        Appointment.     Subject to the terms and conditions of this Agreement, the Companyhereby appoints Agent as its exclusive Agent to (i) assist the
Company in obtaining governmental approvals of the Products in the Territory Countries, (ii) facilitate the registration of the
Products in the Territory Countries, (iii) identify and present to the Company distributors for the Company’s Products in
the Territory Countries, and (iv) subject to Agent meeting the requirements set forth in Section 7(b) below, enter into distribution
agreements with the Territory Organizations to distribute the Products in the Territory Countries. Agent hereby accepts such appointment
and agrees not to use a third party to perform its obligations pursuant to this Agreement without the prior written consent of
the Company. Except as permitted in Section 7 below, it is expressly agreed that Agent has no authority to enter into agreements
or make any commitments on the Company’s behalf and shall not in any way represent itself as a representative that is able
to bind the Company to any contract with a third party.

 

(b)        Duties
and Representations of Agent.     Agent represents and warrants to the Company that: (i) Agent has full legal authority to enter
into this Agreement and provide the services hereunder, and this Agreement constitutes the legal, valid and binding obligation
of Agent enforceable against Agent in accordance with its terms. Neither any of the terms of this Agreement nor the performance
by Agent of work hereunder does or will violate the terms of any agreement between Agent and any third party; and (ii) Agent will
perform all work hereunder in a professional manner and shall satisfy all requirements under this Agreement and at all times adhere
strictly to all of the Company’s standards and policies as they shall be communicated to Agent from time to time, as well
as all applicable laws, rules and regulations, including, without limitation, the Foreign Corrupt Practices Act, 15 U.S.C. §
78dd-1, et seq., and all laws in the Territory requiring Agent to register as an agent of a foreign pharmaceutical manufacturer.

 

(c)        Restrictions
on Company’s Activities.  Subject to Section 2(d) below, the Company shall not, and shall procure an undertaking from
its agents or other intermediaries for territories other than the Territory that they will not engage in any activities relating
to the Products in the Territory.

 

    	2

    	 

    

 

(d)        Reservation
of Rights by Company. The Company reserves the right to take the following actions at any time upon ninety (90) calendar days
prior written notice to Agent without liability: (i) add Products to or delete Products from Exhibit A hereto; (ii) modify the
design of or upgrade the Products or any part of the Products; and (iii) sell the Products exclusively, on a direct or indirect
basis, to customers or specific accounts in the Territory.

 

	3.	Product
                                         Pricing, Commissions and Expenses.

 

(a)        Product
Pricing. The Agent shall provide quotes for each Product at the following prices:

 

(i)        Product
1 LodonalTM:     $ 0.65 per pill in Africa for Territory Countries (USD sixty five cents);

 

(ii)       Product
2 LodonalTM:      $ 0.52 per pill in Africa for Territory Organizations (USD fifty two cents);

 

(iii)      Product
3 MENK:      to be determined by the Company, in its sole discretion, and provided to Agent once determined;

 

(iv)      Product
4 LodonalTM (for the treatment of cancer): to be determined by the Company, in its sole discretion, and provided to
Agent once determined.

 

Any
proposal at other prices or terms and conditions must be approved in advance and in writing by the Company. The Company shall
have the right, from time to time in its sole discretion, to amend prices.

 

(b)        Commissions.
The Company shall pay to Agent, as compensation for Agent’s services during the Term, the following commissions:

 

(i)        Product 1 LodonalTM:   12.5% of Gross Revenues;

 

(ii)       Product
2 LodonalTM:   12.5% of Gross Revenues;

 

(iii)      Product
3 MENK:   to be determined by the Company, in its sole discretion, provided not less than 12.5% of Gross Revenues;

 

(iv)      Product
4 LodonalTM (for the treatment of cancer): to be determined by the Company in its sole discretion, provided not less
than 12.5% of Gross Revenues.

 

In
the event that Agent presents a distributor of the Products to the Company, and the Company enters into a distribution agreement
with such distributor, Agent shall be paid an additional one percent commission of Gross Revenues for Products purchased from
the Company by such distributor.

 

The
Company shall make commission payments to Agent immediately after the Company receives payment of Gross Revenues by wire transfer
utilizing the wire instructions set forth in Exhibit D. The Company shall furnish the Agent with an itemized statement setting
forth the computation of commissions.

 

(c)        Commissions
Due Upon Termination.    In the event of termination of this Agreement for any reason, the Company shall be obligated to pay
commissions only with respect to Gross Revenues prior to termination of this Agreement.

 

(d)        Expenses.
Any of Agent’s expenses must be approved in advance and in writing by the Company in order to be eligible for reimbursement.

 

    	3

    	 

    

 

	4.	Ownership
                                         of Intellectual Property.

 

(a)       Ownership.
Agent acknowledges the Company’s exclusive ownership in the Trademarks, patents, formulations, certificates of free sale,
clinical data and governmental approvals relating to the Products and acquires no right, title or interest in or to any of the
foregoing. Any and all goodwill associated with the Company’s intellectual property will inure exclusively to the benefit
of the Company. During the Term, Agent shall not attempt to register any of the Trademarks or any trademarks, service marks, logos,
brand names, trade names, domain names and/or slogans confusingly similar to the Trademarks. Agent shall execute such documents
and do all such acts and things as may be necessary in the Company’s reasonable opinion to establish Company’s ownership
of any rights in and to the Company’s intellectual property, at the Company’s expense.

 

(b)        Grant
of Rights. The Company hereby grants to Agent for the Term, and subject to the terms and conditions herein, a non-exclusive,
non-transferable, revocable right to use the Trademarks in connection with the marketing and promotion of the Products in the
Territory in accordance with the terms and conditions of this Agreement and any guidelines issued by the Company from time to
time. During the Term, Agent shall have the right to indicate to the public that it is an authorized Agent of the Products.

 

(c)        No
Rights in Intellectual Property. Agent acknowledges and confirms that this Agreement shall not confer on it any right, title
or interest in the Trademarks, patents, formulations, clinical data, certificates of free sale and governmental approvals relating
to the Products and that the sole and exclusive right to and benefit of any of the foregoing and the related goodwill thereto
will remain only in the Company at all times. Agent will take all-reasonable steps in the Territory to protect the Company’s
patents, Trademarks, formulations, clinical data, certificates of free sale and governmental approvals relating to the Products
and shall not represent to any third party that it owns or has any rights in any of the Company’s intellectual property.

 

	5.	Agent’s
                                         Obligations. In addition to such other duties and
                                         obligations as are set forth in this Agreement, the Agent shall: 

 

(a)        Diligently
assist the Company in obtaining governmental approvals of the Products in the Territory Countries;

 

(b)        Facilitate
the registration of the Products in the Territory Countries;

 

(c)        Identify
and present to the Company distributors for the Company’s Products in the Territory Countries;

 

(d)        Provided
Agent meets the requirements set forth in Section 7(b) of this Agreement, enter into agreements with the Territory Organizations
to distribute the Products in the Territory Countries;

 

(e)        Develop
promotional materials for the Products appropriate for use in the Territory, including modification of the Company’s promotional
materials, subject to the Company’s advance approval of such materials;

 

(f)        Participate
in trade shows and exhibitions in the Territory Countries where such participation will promote the Products;

 

(g)        Assist
the Company in providing support services to distributors of the Products inthe Territory Countries;

 

(h)        Fully
and promptly answer all communications from the Company and its distributors in the Territory Countries;

 

    	4

    	 

    

 

(i)        When
a prospective distributor is identified by Agent, establish direct communication between the Company and such prospective distributor;
and

 

(j)        Prepare
and maintain, and submit to the Company on a timely basis, all documentation and reports reasonably required from time to time
to be prepared, maintained or submitted, including but not limited to, the following: (i) a monthly activity report; (ii) a quarterly
report concerning current and prospective distributors; and (iii) a quarterly plan describing expected activities in such quarter
related to the Agent’s services under this Agreement. All documentation and reports shall comply with any guidelines issued
by the Company from time to time.

 

	6.	Company’s
                                         Obligations. In addition to such other duties and
                                         obligations as are set forth in this Agreement, the Company shall:

 

(a)        Assist
Agent by providing an adequate supply of Product data sheets, price lists, catalogues and other promotional literature at no charge
to Agent;

 

(b)
Provide to Agent samples of the Products;

 

(c)        Provide
Product training and field support at no charge to Agent, with the frequency and content of the training and/or support to be
determined by the Company; and

 

(d)        Place
advertisements in applicable publications and participate in trade shows and exhibitions where such participation will promote
the Products.

 

	7.	Product
                                         Distribution.

 

(a)        Distribution
in Territory Countries. All proposals made by Agent to prospective distributors shall promptly be forwarded to the Company.
If a distributor sourced by Agent offers to distribute the Products in the Territory Countries, Agent shall promptly present such
offer to the Company. The Company shall have the right, in its sole and absolute discretion, to accept or reject any such distributor
offer. If the Company accepts an offer from a distributor sourced by Agent, the Company, or an affiliate of the Company selected
by the Company in its sole discretion, shall directly enter into an agreement with such distributor. In a situation where it is
more advantageous for Agent to directly enter into an agreement with a distributor, as determined by the Company in its sole discretion,
the Company shall consider permitting Agent to enter into such direct agreement subject to Agent meeting all applicable requirements
set forth in Section 7(b) below.

 

(b)        Distribution
for Territory Organizations. Subject to the Company’s prior written approval, Agent shall be permitted to enter into
distribution agreements directly with Territory Organizations; provided, however, that Agent (i) has met any and all requirements
necessary to act in that capacity, including, without limitation, all laws, rules and regulations and any criteria established
by a Territory Organization, (ii) has provided all documentation and certifications evidencing that Agent has met such requirements,
and (iii) enters into an agreement with the Company setting forth the terms and conditions of the distribution related to any
such Territory Organization.

 

	8.	Confidentiality.

 

(a)        
Unless otherwise agreed to in advance and in writing by the Company or except as expressly permitted by this Agreement, Agent
will not, except as required by law or court order, use Confidential Information or disclose it to any third party. Agent may
disclose Confidential Information only to those of its employees or contractors who need to know such information. In addition,
prior to any disclosure of such Confidential Information to any such employee or contractor, such employee or contractor shall
be made aware of the confidential nature of the Confidential Information and shall execute, or shall already be bound by, a non-disclosure
agreement containing terms and conditions consistent with the terms and conditions of this Agreement. In any event, Agent shall
be responsible for any breach of the terms and conditions of this Agreement by any of its employees or contractors. Agent shall
use the same degree of care to avoid disclosure of Confidential Information as Agent employs with respect to its own Confidential
Information of like importance, but not less than a reasonable degree of care.

 

    	5

    	 

    

 

(b)        
Agent acknowledges that, during the course of Agent’s performance under this Agreement, Agent has or will receive material
nonpublic information that, if known to the public, would affect IMUN’s stock price. Agent, and any of its members, shall
not (i) purchase or sell IMUN’s stock or any equity instrument related to IMUN’s stock “on the basis of,”
as such term is defined in Rule 10b5-1 of the Securities and Exchange Act of 1934, any material nonpublic information disclosed
in discussions and exchanges between IMUN and Agent until such material nonpublic information is disclosed to the public, and/or
(ii) disclose any material nonpublic information to any third party.

 

(c)        
Upon the termination or expiration of this Agreement for any reason, or upon the Company’s earlier request, Agent will deliver
to the Company all of the Company’s property or Confidential Information in tangible form that Agent may have in its possession
or control.

 

	9.	Infringement
                                         of Intellectual Property Rights. Agent agrees that
                                         if it is notified or otherwise obtains knowledge of any actual or alleged infringement
                                         of the Trademarks or any other intellectual property rights of the Company by a third
                                         party, Agent will promptly notify the Company. No legal proceedings shall be instituted
                                         by Agent against any third party in respect of any such actual or alleged infringement
                                         without the prior written consent of the Company. Agent shall cooperate fully with the
                                         Company in any legal proceedings instituted by the Company, at the Company’s expense.

 

	10.	Term
                                         and Termination.

 

(a)        
Term. This Agreement shall commence on the Effective Date and shall, unless earlier terminated pursuant to Section 10(b),
10(c) or 16(a) below, continue for a term of five (5) years following the Effective Date (the “Initial Term”).
Upon expiration of the Initial Term, this Agreement shall automatically renew for additional one (1) year terms unless terminated
by either Party upon ninety (90) calendar days written notice to the other Party prior to the expiration of the Initial Term or
any renewal term.

 

(b)        
Termination Without Cause. After the Initial Term, this Agreement may be terminated by the Company at any time for any
reason by giving ninety (90) calendar days written notice of such termination to Agent. Agent may terminate this Agreement at
any time for any reason by giving ninety (90) calendar days written notice of such termination to the Company.

 

(c)        
Termination for Material Breach. This Agreement may be terminated by either Party by giving sixty (60) calendar days written
notice of such termination to the other Party in the event of a material breach by the other Party. “Material breach”
shall include: (i) any violation of the terms of Sections 2(a), 2(b), 2(c), 3, 4, 5, 7, 8, 9 and/or 15; (ii) any other breach
that a Party has failed to cure within sixty (60) calendar days after receipt of written notice by the other Party; (iii) any
activity or assistance by Agent of challenging the validity or ownership of the Trademarks or any other intellectual property
rights of the Company; (v) an act of gross negligence or willful misconduct of a Party; and/or (vi) the insolvency, liquidation
or bankruptcy of a Party.

 

(d)        
Effect of Termination. Upon termination of this Agreement, Agent shall cease all activities under this Agreement and promptly
return to the Company all promotional literature and other similar materials or effects which the Company may have furnished to
Agent in connection with its activities hereunder. Upon any termination of this Agreement, the Company shall not be liable to
Agent for loss of future commissions, goodwill, investments, or promotional costs or like expenses.

 

    	6

    	 

    

 

	11.	Force
                                         Majeure.   Either Party shall be excused
                                         from any delay or failure in performance required hereunder if caused by reason of any
                                         occurrence or contingency beyond its reasonable control, including, but not limited to,
                                         acts of God, acts of war, fire, insurrection, strikes, lock-outs or other serious labor
                                         disputes, riots, earthquakes, floods, explosions or other acts of nature. The obligations
                                         and rights of the Party so excused shall be extended on a day-to-day basis for the time
                                         period equal to the period of such excusable interruption. When such events have abated,
                                         the Parties’ respective obligations hereunder shall resume. In the event the interruption
                                         of the excused Party’s obligations continues for a period in excess of ninety (90)
                                         calendar days, either Party shall have the right to terminate this Agreement upon thirty
                                         (30) calendar days’ prior written notice to the other Party.

 

	12.	Limitation
                                         of Liability. Except for violations of Sections
                                         4, 8 or 9, neither Party shall be liable to the other Party for any special, incidental,
                                         consequential, indirect or punitive damages arising in any way out of this Agreement,
                                         however caused and on any theory of liability.

 

	13.	Independent
                                         Contractors. It is understood that both Parties
                                         hereto are independent contractors and engage in the operation of their own respective
                                         businesses. Neither Party hereto is to be considered the agent of the other Party for
                                         any purpose whatsoever and neither Party has any authority to enter into any contract
                                         or assume any obligation for the other Party or to make any warranty or representation
                                         on behalf of the other Party. Each Party shall be fully responsible for its own employees,
                                         servants and agents, and the employees, servants and agents of one Party shall not be
                                         deemed to be employees, servants and agents of the other Party for any purpose whatsoever.

 

	14.	Non-Competition.
                                         During the Term and for a period of one (1) year
                                         after voluntary termination of the Agreement by Agent or termination by the Company pursuant
                                         to Section 10(c) hereof, Agent shall not, directly or indirectly, market, sell or promote
                                         the sale of, or otherwise commercially deal in or with, any products or services within
                                         the Territory Countries that will then be in competition with the Products.

 

	15.	Indemnification
                                         by Agent. Agent shall defend, indemnify, and hold
                                         harmless the Company and the Company’s officers, directors, shareholders, agents
                                         and employees from and against any and all third party losses, liabilities, damages,
                                         demands, suits, causes of action, judgments, costs or expenses (including court costs
                                         and reasonable attorney fees) resulting from or directly or indirectly arising out of
                                         or in connection with this Agreement and the transactions contemplated hereby, including
                                         but not limited to: (a) any claim that any negligent acts or omissions of Agent caused
                                         personal injury, death, property damage, or any other legal or equitable wrong; (b) any
                                         obligation or tax liability imposed on the Company resulting from Agent’s being
                                         determined not to be an independent contractor; and (c) a breach of any covenant, representation
                                         or warranty made herein by Agent. The Company shall have the right to approve any counsel
                                         retained to defend any demand, suit, or cause of action in which the Company is a defendant,
                                         such approval not to be unreasonably withheld. Agent agrees that the Company shall have
                                         the right to control and participate in the defense of any such demand, suit or cause
                                         of action concerning matters that relate to the Company, and that such suit will not
                                         be settled without the Company’s consent, such consent not to be unreasonably withheld.
                                         If, in the Company’s judgment, a conflict exists in the interests of the Company
                                         and Agent in such demand, suit, or cause of action, the Company may retain its own counsel
                                         whose fees shall be paid by Agent. Nothing herein shall be construed as making Agent
                                         liable for any injury or damage caused solely by the negligence or wrongdoing of the
                                         Company.

 

    	7

    	 

    

 

	16.	Royalty.

 

(a)        Royalty
on Product in the Event of Sale. In the event there is a consummation of the sale or disposition by the Company of all or
substantially all of the Company’s assets, whether by purchase, merger or otherwise, the Company shall have the right to
terminate this Agreement immediately. If the Company exercises such right to terminate, the Company shall pay Agent a royalty
in perpetuity in an amount equal to one percent (1%) of Net Product Sales. “Net Product Sales” means funds
actually received by the Company from the sale of the Products in the Territory, after deduction, where applicable, for: (i) discounts,
including cash discounts or other rebates, (ii) freight, postage, transportation, insurance and duties on shipment of Products,
(iii) special packing charges, and (iv) any tax, government charge or duty (including any tax such as value added or similar tax)
levied on the sale, transportation or delivery of the Products.

 

(b)        Reports;
Method of Payment. In the event Agent is entitled to a royalty in accordance with Section 16(a) above, within thirty (30)
days following the close of each Fiscal Quarter, the Company shall furnish to Agent a written report for such Fiscal Quarter showing
(i) the quantity of Product sold by the Company in the Territory, (ii) the monetary amount of such sales, and (iii) the royalty
payable under this Agreement for such Fiscal Quarter. Simultaneously with the submission of the written report, the Company shall
pay to Agent a sum equal to the aggregate royalty due for such Fiscal Quarter calculated in accordance with this Agreement. The
amount of any royalty payable under this Agreement in respect of any Fiscal Quarter shall be payable in cash. Cash payments to
be made by the Company to Agent under this Agreement shall be paid in United States dollars by bank wire transfer in immediately
available funds in accordance with the wire instructions set forth in Exhibit D.

 

	17.	Successors
                                         and Assignment. This Agreement will be binding
                                         upon and inure to the benefit of any successor of the Company. Any such successor of
                                         the Company will be deemed substituted for the Company under the terms of this Agreement
                                         for all purposes. For this purpose, “successor”
                                         means any person, firm, corporation or other business entity which at any time, whether
                                         by purchase, merger or otherwise, directly or indirectly acquires all or substantially
                                         all of the assets or business of the Company. Neither Party may, without prior written
                                         approval of the other, assign this Agreement or transfer its interest or any part thereof
                                         under this Agreement to any third party; provided, however, that a Party may assign
                                         its rights or obligations to a third party in connection with the merger, reorganization
                                         or acquisition of stock or assets affecting all or substantially all of the properties
                                         or assets of the assigning Party.

 

	18.	Injunctive
                                         Relief. Agent acknowledges and agrees that a violation
                                         of Section 4, 8 or 9 would cause immediate and irreparable harm for which money damages
                                         would be inadequate. Therefore, the Company will be entitled to injunctive relief for
                                         Agent’s breach of any of its obligations under Section 4, 8 or 9 without proof
                                         of actual damages and without the posting of bond or other security. Such remedy shall
                                         not be deemed to be the exclusive remedy for such violation, but shall be in addition
                                         to all other remedies available at law or in equity.

 

	19.	Governing
                                         Law. This Agreement shall be governed by the laws
                                         of the State of Florida applicable to all agreements made and to be fully performed therein,
                                         excluding conflicts of law provisions thereof. Any claim or controversy arising among
                                         or between the parties hereto and any claim or controversy arising out of or respecting
                                         any matter contained in this Agreement or any difference as to the interpretation of
                                         any of the provisions of this Agreement shall be settled by arbitration in Orlando, Florida
                                         by three (3) arbitrators under the then prevailing rules of the American Arbitration
                                         Association. In any arbitration involving this Agreement, the arbitrators shall not make
                                         any award, which will alter, change, cancel or rescind any provision of the Agreement
                                         and their award shall be consistent with the provisions of this Agreement. Any such arbitration
                                         must be commenced no later than one (1) year from the date such claim or controversy
                                         arose. The award of the arbitrators shall be final and binding and judgment may be entered
                                         in any court of competent jurisdiction. In addition to the foregoing, the Company may
                                         apply to any court of appropriate jurisdiction for any of the provisional remedies it
                                         may be entitled to, including but not limited to injunction or attachment, pending the
                                         determination of any claim or controversy pursuant to the arbitration provisions of this
                                         Agreement. Service of process and notice of arbitration of any and all documents and
                                         papers may be made either by Certified or Registered mail, addressed to either party
                                         at the addresses listed in this Agreement.

 

    	8

    	 

    

 

	20.	Notices.
                                         All notices, demands or other communications given
                                         hereunder shall be deemed to have been duly given only upon hand delivery thereof or
                                         upon the first business day after delivery to a reputable international overnight courier
                                         service for overnight delivery, addressed as set forth below, or to such other address
                                         or such other person as either Party shall designate in writing to the other for such
                                         purposes and in the manner set forth herein. 

 

Notices
to Agent are to be addressed as follows: 

 

GB
Global Group

Attention:
Dr. Estelle-Marie Heussen, Ph.D

330
15th St., S.E. 

Washington
D.C. 20003 

 

Notices
to the Company are to be addressed as follows: 

 

Immune
Therapeutics, Inc. 

Attention:
Corporate Counsel

37
North Orange Avenue, Suite 607

Orlando,
Florida 32801

 

	21.	General.
                                         This Agreement constitutes the entire agreement
                                         of the Parties on the subject hereof and supersedes all prior understandings and instruments,
                                         including, without limitation, the Original Agency Agreement. This Agreement may not
                                         be modified other than by a written instrument executed by duly authorized representatives
                                         of the Parties. No delay or failure by the Company to exercise any right under this Agreement,
                                         and no partial or single exercise of that right, will constitute a waiver of that or
                                         any other right provided herein, and no waiver of any violation of any term or provision
                                         of this Agreement will be construed as a waiver of any succeeding violation of the same
                                         or any other provision of the Agreement.

 

	22.	Survival
                                         of Provisions. The following provisions of this
                                         Agreement shall survive the termination of this Agreement: Sections 8, 14, 15, 16, 18,
                                         19 and 22 and all other provisions of this Agreement that by their nature extend beyond
                                         the termination of this Agreement.

 

Signatures
Appear on the Following Page 

 

    	9

    	 

    

 

IN
WITNESS WHEREOF, and intending to be legally bound, the Parties have duly executed this Agreement as of the Effective Date.

 

	IMUN:	 	
	 	 	 
	Immune
    Therapeutics, Inc.	 	TNI
    BioTech International, Ltd.
	 	 	 	 
	By:	/s/
    Chris Pearce 	 	By:	/s/
    Chris Pearce
	 	Chris
    Pearce, Chief Operating Officer	 	 	Chris
    Pearce, President

 

	Agent:	 
	 	 	 
	GB
    Pharma Holdings, LLC	 
	 	 	 
	By:
    	/s/
    Dr. Gloria Herndon 	 
	 	Dr.
    Gloria Herndon, Managing Member	 

 

ACKNOWLEDGED
AND AGREED:

 

The
undersigned hereby acknowledge and agree that the Original Agency Agreement is terminated as of the Effective Date and this Agreement
supersedes the Original Agency Agreement.

 

	GBPH:	 	AIRMED:
	 	 	 
	GB
    Pharma Holdings, Inc.	 	Airmed
    Biopharma Limited 
	 	 	 	 	 
	By:	/s/
    Dr. Gloria Herndon	 	By:	/s/
    Chris Pearce 
	 	Dr.
    Gloria Herndon, President	 	 	 Chris
    Pearce

 

    	10

    	 

    

 

EXHIBIT
A – PRODUCTS

 

	 	●	A
    product for human use formulated by the Company utilizing the Company’s patent and/or licensing rights relating to Low
    Dose Naltrexone (LDN); Trademark: LodonalTM
	 	 	 
	 	●	A
    product for human use formulated by the Company utilizing the Company’s patent and/or licensing rights relating to Methionine-Enkephalin
    (MENK)

 

    	11

    	 

    

 

EXHIBIT
B – TERRITORY COUNTRIES

 

	 	●	Economic
    Community of West African States (ECOWAS) countries
	 	 	 
	 	●	Economic
    Community of Central Africa (ECCAS) countries
	 	 	 
	 	●	The
    Arab Maghreb Union (AMU/UMA) countries
	 	 	 
	 	●	The
    East African Community (EAC) countries
	 	 	 
	 	●	The
    Intergovernmental Authority on Development (IGAD) countries
	 	 	 
	 	●	The
    Southern African Development Community (SADC) countries
	 	 	 
	 	●	The
    Common Market for Eastern and Southern Africa (COMESA) countries
	 	 	 
	 	●	The
    Community of Sahel-Saharan States (CENSAD) countries
	 	 	 
	 	●	West
    and Central African Franc countries

 

Agent
and the Company hereby acknowledge and agree that the Caribbean countries and the South East Asia countries (i.e., Brunei, Cambodia,
East Timor, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand and Vietnam) shall be included in the Territory
Countries; provided, however, that the Product pricing and commission terms set forth in Section 3(a) and (b) of this Agreement
shall be revised through reasonable and good faith negotiations between the Parties.

 

Agent
shall have the right of first refusal to other regions and not yet named territories among Central and South America and other
countries with reciprocity in approvals outside of the Territory Countries defined above. In this regard, the Company shall notify
Agent in writing of the offer by another potential agent in any such additional regions or countries, and shall offer Agent the
right to perform its services in such additional regions or countries in line with the terms of this Agreement. Agent shall, upon
receipt of the Company’s written offer, indicate in writing within thirty (30) days of Agent’s acceptance or rejection
of the offer.

 

Agent
hereby acknowledges and agrees that the Engagement Agreement for Business Development & Marketing Services Provided by Brewer
and Associates Consulting, LLC dated June 26, 2016 and entered into between IMUN and Brewer and Associates Consulting, LLC does
not in any way violate Agent’s exclusivity set forth in this Agreement.

 

    	12

    	 

    

 

EXHIBIT
C – TERRITORY ORGANIZATONS

 

	 	●	UNAIDS
	 	 	 
	 	●	PEPFAR
	 	 	 
	 	●	Global
    Fund
	 	 	 
	 	●	Clinton
    Foundation
	 	 	 
	 	●	Melinda
    and Bill Gates Foundation
	 	 	 
	 	●	National
    AIDS Counsel

 

    	13

    	 

    

 

EXHIBIT
D – AGENT’S WIRE INSTRUCTIONS

 

SunTrust

14939
Shady Grove Rd,

Rockville,
MD 20850

Tel
301-795-0857

GB
Pharma Holdings

Acct.
# 1000152928734

ACH
routing number: 061000104

Swift
Code: SNTRUS3A

 

    	14EX-10.1

 Exhibit 10.1 

CRESTWOOD NONQUALIFIED DEFERRED COMPENSATION PLAN 

Effective as of December 1, 2016 

 CRESTWOOD NONQUALIFIED DEFERRED COMPENSATION PLAN 

ARTICLE I 
 PURPOSE;
EFFECTIVE DATE 
  

	1.1.	Purpose. The purpose of this Crestwood Nonqualified Deferred Compensation Plan (hereinafter, the “Plan”) is to permit a select group of highly compensated employees of Crestwood Equity Partners
LP (the “Company”)(and its selected subsidiaries and/or affiliates) and directors on the Board of Directors (the “Board”) of Crestwood Equity GP LLC, the general partner of the Company (the “GP”), to defer the receipt
of income which would otherwise become payable to them. It is intended that this Plan, by providing these eligible individuals an opportunity to defer the receipt of income, will assist in retaining and attracting individuals of exceptional ability.

  

	1.2.	Effective Date. It is the intent that all of the amounts deferred and benefits paid under this Plan will be subject to the terms of Section 409A of the Code and the applicable guidance thereunder, and
that the Plan shall be effective as of December 1, 2016. 

  

	1.3.	Plan Type. For purposes of Section 409A of the Code, the portion of the amounts deferred by the Participants and benefits attributable thereto, shall be considered an elective account balance plan as
defined in Treas. Reg. §1.409A -1(c)(2)(i)(A), or as otherwise provided by the Code; the portion of the amounts deferred as matching or employer discretionary contributions and benefits attributable thereto, shall be considered a nonelective
account balance plan as defined in Treas. Reg. §1.409A -1(c)(2)(i)(B), or as otherwise provided by the Code. 

 ARTICLE
II 
 DEFINITIONS 

For the purpose of this Plan, the following terms shall have the meanings indicated, unless the context clearly indicates otherwise: 

 

	2.1.	Account(s). “Account(s)” means the account or accounts maintained on the books of the Company used solely to calculate the amount payable to each Participant under this Plan and shall not
constitute a separate fund of assets. Account(s) shall be deemed to exist from the time amounts are first credited to such Account(s) until such time that the entire Account Balance has been distributed in accordance with this Plan. The Accounts
available for each Participant shall be identified as: 

  

	 	a)	Company Contribution Account; 

  

	 	b)	Retirement Account; and, 

  

	 	c)	In-Service Account; each Participant may maintain up to five (5) In-Service Accounts based on selecting different times and/or forms of payment as described under Article 5, below. 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 1

	2.2.	Beneficiary. “Beneficiary” means the person, persons or entity as designated by the Participant, entitled under Article VI to receive any Plan benefits payable after the Participant’s death.

  

	2.3.	Board. “Board” means the Board of Directors of Crestwood Equity GP LLC. 

  

	2.4.	Change in Control. A “Change in Control” shall be deemed to have occurred upon the occurrence of one of the following events: (i) any sale, lease, exchange or other transfer (in one or a
series of related transactions) of all or substantially all of the assets of the GP to any Person, other than Crestwood Holdings Partners LLC or any of its affiliates, or (ii) any merger, reorganization, consolidation or other transaction
pursuant to which more than fifty percent (50%) of the combined voting power of the equity interests in the GP cease to be controlled by Crestwood Holdings Partners LLC or any of its affiliates. 

 

	2.5.	Code. “Code” means the Internal Revenue Code of 1986, as may be amended from time to time. Any reference in this Plan to “applicable guidance”, “further guidance” or other
similar term shall include any proposed, temporary or final regulations, or any other guidance, promulgated with respect to or in connection with Section 409A by the U.S. Department of Treasury or the Internal Revenue Service.

  

	2.6.	Committee. “Committee” means the Committee appointed by the Company to administer the Plan pursuant to Article VII. The initial Committee so designated by the Company shall consist of the
Compensation Committee of the Board. 

  

	2.7.	Company. “Company” means Crestwood Equity Partners LP, a Delaware Limited Partnership, and any directly or indirectly affiliated subsidiary organizations. 

 

	2.8.	Compensation. “Compensation” means, for employees of the Company, the base salary payable to and bonus or incentive compensation earned by a Participant and, for members of the Board, retainers,
fees and equity awards earned by a Participant. For purposes of this Plan only, Compensation shall be calculated before reduction for any amounts deferred by the Participant, if any, pursuant to the Company’s tax qualified plans which may be
maintained under Section 401(k) or Section 125 of the Code, or pursuant to this Plan or any other non-qualified plan which permits the voluntary deferral of compensation. Inclusion of any other forms of compensation is subject to Committee
approval. 

  

	2.9.	 Deferral Commitment. “Deferral Commitment” means a commitment made by a Participant to
defer a portion of Compensation as set forth in Article III, and as permitted by the Committee in its sole discretion. The Deferral Commitment shall apply to each payment of Compensation payable to a Participant, and the Committee is empowered to
group the various types of Compensation together for purposes of effecting the election to defer. By way of example: the Committee may apply the election to defer “salary” to salary, and any other regularly occurring form of compensation;
or the Committee may apply the election to defer “bonus” to annual bonuses, short-term bonuses, long term bonus arrangements and other forms of incentive-based compensation. The Deferral Commitment shall specify the Account or Accounts to
which the Compensation deferred 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 2

	 	
shall be credited. Such designation shall be made in the form of a whole percentage, a whole percentage in excess of a stated dollar amount (for bonus compensation only) or an exact stated dollar
amount, as permitted by the Deferral Commitment form provided to the Participant. A Deferral Commitment with respect to any bonus or incentive compensation which is determined by the Committee to be Performance Based Compensation shall be made as
provided by the Committee, but no later than six (6) months prior to the end of such performance period. Any Deferral Commitment shall be made in a form and at a time deemed acceptable to the Committee. 

 

	2.10.	Deferral Period. “Deferral Period” means each calendar year, except that if a Participant first becomes eligible after the beginning of a calendar year, the initial Deferral Period shall be the
date the Participant first becomes eligible to participate in this Plan through and including December 31st of that calendar year. 

  

	2.11.	Determination Date. “Determination Date” means each business day. 

  

	2.12.	Disability. “Disability means a physical or mental condition whereby the Participant: (i) is unable to engage in any substantial gainful activity by reason of any medically determinable physical
or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, or (ii) is, by reason of any medically determinable physical or mental impairment which
can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, receiving income replacement benefits for a period of not less than three (3) months under an accident and health
plan covering employees of the Participant’s employer. 

  

	2.13.	Discretionary Contribution. “Discretionary Contribution” means the Company contribution credited to a Participant’s Account(s) under Section 4.5, below. 

 

	2.14.	Distribution Election. “Distribution Election” means the form prescribed by the Committee and completed by the Participant, indicating the chosen form of payment for benefits payable from each
Account under this Plan, as elected by the Participant. 

  

	2.15.	Financial Hardship. “Financial Hardship” means a severe financial hardship to the Participant resulting from an illness or accident of the Participant, the Participant’s spouse, or a
dependent (as defined in Section 152(a) of the Code) of the Participant, loss of the Participant’s property due to casualty, or other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the control of
the Participant. 

  

	2.16.	401(k) Plan. “401(k) Plan” means the “Crestwood Operations LLC 401(k) Plan”, or any other successor defined contribution plan maintained by the Company that qualifies under
Section 401(a) of the Code and satisfies the requirements of Section 401(k) of the Code. 

  

	2.17.	GP. “GP” means Crestwood Equity GP LLC. 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 3

	2.18.	Interest. “Interest” means the deemed earnings credited to a Participant’s Account(s), which is an amount that is calculated quarterly at the then current U.S. Prime Rate of interest plus
two hundred (200) basis points. Interest shall be credited no later than the fifteenth (15th) of the month following the end of such quarter. . 

  

	2.19.	Matching Contribution. “Matching Contribution” means the Company contribution credited to a Participant’s Account(s) under Section 4.4, below, as determined by the Committee in its sole
discretion. 

  

	2.20.	Participant. “Participant” means any individual who is eligible, pursuant to Section 3.1, below, to participate in this Plan, and who either, has elected to defer Compensation under this
Plan in accordance with Article III, below, or who is determined by the Committee in their sole discretion as being eligible to receive a Discretionary Contribution under this Plan. Such individual shall remain a Participant in this Plan for the
period of deferral, or credit, and until such time as all benefits payable under this Plan have been paid in accordance with the provisions hereof. 

  

	2.21.	Performance Based Compensation. “Performance Based Compensation” means the portion of Compensation determined by the Committee to satisfy the requirements set forth in Treas. Reg.
§1.409A-1(e), and such Performance Based Compensation may be determined on a fiscal or calendar year basis. 

  

	2.22.	Plan. “Plan” means this Crestwood Nonqualified Deferred Compensation Plan, as amended from time to time. 

  

	2.23.	Retirement. “Retirement” means the Termination of a Participant’s employment with the Company or membership on the Board, as applicable (for reasons other than death or Disability) after the
Participant’s attainment of age sixty-five (65) or attainment of age sixty (60) with at least five (5) years of continuous service with the Company or the Board, as applicable. 

 

	2.24.	Specified Employees. “Specified Employees” means a Participant who is determined by the Committee to be a “specified employee” under the provisions of Treas. Reg. §1.409A-1(i) and
other applicable guidance, provided that the Company (or a member of the same group of controlled entities as the Company) is publicly traded on an established stock exchange. 

 

	2.25.	Termination. “Termination”, “terminates employment” or any other similar such phrase means a Participant’s “separation from service” with the Company or the Board, for
any reason, within the meaning of Section 409A of the Code, and Treas. Reg. §1.409A-1(h) and other applicable guidance. 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 4

 ARTICLE III- ELIGIBILITY AND PARTICIPATION 

 

	3.1.	Eligibility and Participation. 

  

	 	a)	Eligibility. Eligibility to participate in the Plan shall be limited to those select key employees of the Company and directors of the Board who are designated by the Committee from time to time, and approved by the
Compensation Committee of the GP. 

  

	 	b)	Participation. An individual’s participation in the Plan shall be effective upon the individual first becoming eligible to participate, and the earlier of (i) a contribution under this Plan being made on
behalf of the Participant by the Company or (ii) the completion and submission of a Deferral Commitment, Fund Allocation Form, and Distribution Election to the Committee at a time and in a form determined by the Committee. 

 

	 	c)	First-Year Participation. When an individual first becomes eligible to participate in this Plan, and is not a participant in another plan sponsored by the Company that is considered to be of a similar type as defined in
Treas. Reg. §1.409A -1(c)(2)(i)(A) or (B), or as otherwise provided by the Code, a Deferral Commitment may be submitted to the Committee within thirty (30) days after the individual first becomes eligible to participate. Such Deferral
Commitment will be effective only with regard to Compensation earned and paid with respect to services performed following submission of the Deferral Commitment to the Committee. 

 

	3.2.	Form of Deferral Commitment. A Participant may elect to make a Deferral Commitment at such other time and in such form as determined by the Committee, but in no event later than the date on which the
election is required to become irrevocable as set forth in this Article or otherwise required by Section 409A of the Code and applicable guidance. The Deferral Commitment shall specify the following: 

 

	 	a)	Timing of Deferral Election. The Participant shall make an election to defer Compensation by filing a Deferral Commitment with the Committee, and such election shall become irrevocable no later than the last day of the
calendar year prior to the Deferral Period, except as provided in Section 3.1(c), above. In addition, notwithstanding anything to the contrary, a Deferral Commitment with respect to Performance Based Compensation may be filed with the Committee
and such election shall become irrevocable no later than six (6) months before the end of the performance period on which such Performance Based Compensation is based, provided such Participant has been continuously employed with the Company
from the later of the beginning of the performance period or the date on which the performance criteria for such Performance Based Compensation was established. 

  

	 	b)	 Deferral Amounts; Accounts. A Deferral Commitment may be made with respect to each payment and/or type of
Compensation payable by the Company to a Participant during the Deferral Period, and shall designate the portion of each deferral that shall be allocated among the various Retirement or In-Service Accounts. In addition, no amounts shall be deferred
into an In-Service Account during a Deferral Period when payments are scheduled to be made from such 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 5

	 	
Account and until such time as that entire Account balance has been completely distributed. Notwithstanding anything to the contrary, for purposes of this Plan only, base salary attributable to
the final pay period of any calendar year shall be deemed to be earned in the subsequent calendar year, provided the amounts are in fact paid (or payable) in the subsequent calendar year under the Company’s normal compensation practices. The
Participant shall set forth the amount to be deferred in the manner provided by the Committee. 

  

	 	c)	Maximum Deferral. The maximum amount of salary that may be deferred shall be fifty percent (50%); the maximum amount of bonus or incentive compensation that may be deferred shall be one-hundred (100%) percent.

  

	3.3.	Period of Deferral Commitment. Any Deferral Commitment, once irrevocable as described in Section 3.4, below, made by a Participant with respect to Compensation shall remain in effect for the entire
relevant Deferral Period. 

  

	3.4.	Irrevocability of Deferral Commitment. A Deferral Commitment shall become irrevocable by the Participant as of the last day on which an election may be made under the terms of this Plan, and remains
irrevocable through the end of the applicable Deferral Period. 

  

	3.5.	Change in Status. If the Committee determines that a Participant’s employment performance is no longer at a level that warrants reward through participation in this Plan, but does not Terminate the
Participant’s employment with the Company, the Participant’s existing Deferral Commitment shall terminate at the end of the Deferral Period, and no new Deferral Commitment may be made by such Participant after notice of such determination
is given to the Participant by the Committee. If a former Participant becomes designated again to participate in the Plan, such Participant shall complete a new Deferral Commitment. 

 

	3.6.	Defaults in Event of Incomplete or Inaccurate Deferral Documentation. In the event that a Participant submits a Deferral Commitment, Fund Allocation Form or Distribution Election to the Committee that
contains information necessary to the efficient operation of this Plan but which, in the sole discretion of the Committee, is missing, incomplete or inaccurate, the Committee shall be authorized to treat such form as if the following elections had
been made by the Participant, and such information shall be communicated to the Participant: 

  

	 	a)	If no Account is listed, treat as if the Retirement Account was elected; 

  

	 	b)	If the sum of the percentages listed for the Accounts equals less than 100%, treat as if the balance was deferred into Retirement Account; 

 

	 	c)	If the sum of the percentages listed for the Accounts equals more than 100%, proportionately reduce each Account until the sum equals 100%; 

 

	 	d)	If In-Service Account is listed, but no deferrals can be made into that Account due to the fact that benefits are scheduled to be paid or are being paid from that In- Service Account, then the amounts elected to be
deferred shall be credited to the Retirement Account; 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 6

	 	e)	If no Distribution Election is chosen, treat as if lump sum was elected for In-Service Account and treat as if three (3) year installments was elected for Retirement Account and/or Company Contribution Account;
and, 

  

	 	f)	If no time of payment is chosen for In-Service Account, treat as if the earliest possible date available under the provisions of Section 5.2, below, was elected. 

ARTICLE IV- DEFERRED COMPENSATION ACCOUNT 
  

	4.1.	Accounts. The Compensation deferred by a Participant under the Plan, any Matching or Discretionary Contributions and Interest shall be credited to the Participant’s Account(s) as selected by the
Participant, or as otherwise provided in this Article or Section 3.6. Separate accounts may be maintained on the books of the Company to reflect the different Accounts chosen by the Participant, and the Participant shall designate the portion
of each deferral that will be credited to each Account as set forth in Section 3.2(a), above. These Accounts shall be used solely to calculate the amount payable to each Participant under this Plan and shall not constitute a separate fund of
assets. 

  

	4.2.	Timing of Credits; Withholding. A Participant’s deferred Compensation shall be credited to each Account designated by the Participant as soon as practicable after the date the Compensation deferred
would have otherwise been payable to the Participant. Any Matching and/or Discretionary Contributions shall be credited to the appropriate Account(s) as provided by the Committee. Any withholding of taxes or other amounts with respect to deferred
Compensation or other amounts credited under this Plan that is required by local, state or federal law shall be withheld from the Participant’s corresponding non-deferred portion of the Compensation to the maximum extent possible, and any
remaining amount shall reduce the amount credited to the Participant’s Account in a manner specified by the Committee. 

  

	4.3.	Distribution Equivalents. A Participant’s equity-based contributions to the Plan shall earn distribution equivalents only if the related award agreement expressly provides for such distribution
equivalents. Any distribution equivalents credited to the Plan shall be held in the Participant’s Account and credited with Interest. 

  

	4.4.	Matching Contributions. The Company may make a Matching Contribution to the Retirement Account of any Participant designated by the Committee, using the current matching contribution formula used in the
401(k) Plan; if the Company makes Matching Contributions for any calendar year, such Matching Contributions shall be made with the assumption that the Participant made the maximum allowed deferral into the 401(k) Plan. The Matching Contribution
shall be credited to the Retirement Account as soon as practicable after the end of the Deferral Period, but in no event later than ninety (90) days after the close of such year. 

 

	4.5.	 Discretionary Contributions. In its sole discretion, the Company and/or the GP may make
Discretionary Contributions to a Participant’s Account. Discretionary Contributions 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 7

	 	
shall be credited at such times and in such amounts as recommended by the Committee and approved by the Compensation Committee of the GP, or the Board in its sole discretion. Unless the Committee
specifies otherwise, such Discretionary Contributions shall be allocated to the Company Contribution Account. 

  

	4.6.	Determination of Accounts. Each Participant’s Account as of each Determination Date shall consist of the balance of the Account as of the immediately preceding Determination Date, adjusted as follows:

  

	 	a)	New Deferrals. Each Account shall be increased by any deferred Compensation credited since such prior Determination Date in the proportion chosen by the Participant, except that no amount of new deferrals shall be
credited to an Account at the same time that a distribution is to be made from that Account. 

  

	 	b)	Company Contributions. Each Account shall be increased by any Discretionary and/or Matching Contributions credited since such prior Determination Date as set forth above in Sections 4.4, and 4.5. 

 

	 	c)	Distributions. Each Account shall be reduced by the amount of each benefit payment made from that Account since the prior Determination Date. 

 

	4.7.	Interest. Each Account shall be increased by the Interest credited to such Account and shall reflect the Account balance from the prior Determination Date and amounts under (a), (b), and (c) above, as
determined by the Committee in its sole discretion. 

  

	4.8.	Vesting of Accounts. Each Participant shall be vested in the amounts credited to such Participant’s Account and Interest thereon as follows: 

 

	 	a)	Amounts Deferred. A Participant shall be one hundred percent (100%) vested at all times in the amount of Compensation elected to be deferred under this Plan, including any Interest thereon. 

 

	 	b)	Matching Contributions. A Participant shall be vested in the amount of Matching Contributions credited under this Plan, including any Interest thereon, in the same percentage as the Participant is vested in the Matching
Contributions in the 401(k) Plan or any subsequent 401(k) plan sponsored by the Company, except as provided in (d), below. If a Participant Terminates employment prior to becoming fully vested in certain Matching Contributions under this Plan, such
Participant shall forfeit the unvested Matching Contributions, except as provided in (e) and (f) below. 

  

	 	c)	Discretionary Contributions. A Participant’s Discretionary Contributions and Interest thereon shall become vested as determined by the Committee, except as provided in (d), below. If a Participant Terminates
employment prior to becoming fully vested in certain Discretionary Contributions under this Plan, such Participant shall forfeit the unvested Discretionary Contributions, except as provided in (e) and (f) below. 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 8

	 	d)	In the event of a Change in Control. In the event of a Change in Control, any unvested Matching Contributions, Discretionary Contributions and Interest will become vested immediately. 

 

	 	e)	In the event of a Participant’s Termination of employment without Cause, any unvested Matching Contributions, Discretionary Contributions and Interest will become vested on a pro-rated basis, based on the number of
months the Participant provided services to the Company during the applicable vesting period. For purposes of this Plan, “Cause” shall be defined for employees as defined in the Participant’s employment agreement with the Company. In
the event an employee does not have a definition of “Cause” in his or her employment agreement with the Company or in the case of a director of the GP, the definition of “Cause” shall be the termination of the Participant by the
Company for any of the following: if the Participant (i) has been indicted or convicted of, or has entered a plea of guilty or nolo contendere to, a felony charge or crime involving moral turpitude, or, in the course of the Participant’s
employment has engaged in fraudulent or criminal activity (whether or not prosecuted), (ii) has failed to follow reasonable directions of the Company, provided that the foregoing failure shall not be “Cause” if the Participant in good
faith believes that such direction is illegal and promptly so notifies the Board, (iii) has failed to devote all of the Participant’s professional time to the Company and its affiliates, except as permitted by the Company, (iv) has
materially breached any policy or code of conduct of the Company, (v) has materially breached any provision of the employment agreement or any other agreement between the Participant and the Company or its affiliates, (vi) has received a
kickback or rebate of any fee or expense paid by the Company, (vii) has engaged in the use of illegal drugs, the persistent excessive use of alcohol, or any other activity that materially impairs the Participant’s ability to perform the
Participant’s duties hereunder or results in conduct bringing the Company or its affiliates into substantial public disgrace or disrepute, or (viii) engages in intentional, reckless, or grossly negligent conduct that has or is reasonably
likely to have a material adverse effect on the Company or its affiliates; provided, however, that with respect to subsections (iii), (iv) and (v), the Board may elect, in its sole discretion, to allow the Participant a period of time as
determined by the Board to cure the act, conduct or event constituting Cause under such subsections. 

  

	 	f)	In the event of a Participant’s Termination of employment due to death or Disability, any unvested Matching Contributions, Discretionary Contributions and Interest will become vested immediately. 

 

	4.9.	Statement of Accounts. To the extent that the Company does not arrange for Account balances to be accessible online by the Participant, the Committee shall provide to each Participant a statement showing
the balances in the Participant’s Account no less frequently than annually. 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 9

 ARTICLE V- PLAN BENEFITS 

 

	5.1.	Company Contribution Account. The vested portion of a Participant’s Company Contribution Account shall be distributed to the Participant upon the Participant’s Termination of employment with the
Company. 

  

	 	a)	Timing of Payment. Subject to Section 5.7, benefits payable from the Company Contribution Account shall commence as soon as practicable after the date of the Participant’s Termination, but no later than ninety
(90) days following the Participant’s Termination. 

  

	 	b)	Form of Payment. The form of benefit payment shall be that form selected by the Participant in the first Distribution Election made with respect to the initial crediting of amounts into the Company Contribution Account,
and as permitted pursuant to Section 5.7 below, except that if the Participant terminates employment prior to Retirement, in which event, the Company Contribution Account shall be paid in the form of a lump sum payment. If the Form of Payment
selected provides for installments, such installments shall be made on or about the anniversary of the initial payment. 

  

	5.2.	Retirement Account. The vested portion of a Participant’s Retirement Account shall be distributed to the Participant upon the Participant’s Termination of employment with the Company or
membership on the Board, as applicable. 

  

	 	a)	Timing of Payment. Subject to Section 5.7, benefits payable from the Retirement Account shall commence as soon as practicable after the date of the Participant’s Termination, but no later than ninety
(90) days following the Participant’s Termination. 

  

	 	b)	Form of Payment. The form of benefit payment shall be that form selected by the Participant in the first Deferral Commitment which designated a portion of the Compensation deferred be allocated to the Retirement
Account, and as permitted pursuant to Section 5.7 below, except that if the Participant Terminates employment prior to Retirement, in which event, the Retirement Account shall be paid in the form of a lump sum payment. If the Form of Payment
selected provides for installments, such installments shall be made on or about the anniversary of the initial payment. 

  

	5.3.	In-Service Account. The vested portion of a Participant’s In-Service Account shall generally be distributed to the Participant upon the date specified by the Participant. 

 

	 	a)	 Timing of Payment. Subject to Section 5.7, benefits payable from the In-Service Account shall commence on or
about March 15th of the year specified in the first Deferral Commitment which designated a portion of the Compensation deferred be allocated to the In-Service Account. In no event shall the date selected be earlier than the first day of the
sixth calendar year following the initial filing of the Deferral Commitment with respect to that In-Service Account. In the event that the Participant Terminates employment with the Company prior to the date so specified, the benefits under this
section shall commence as soon as 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 10

	 	
administratively practicable after Termination of employment, but no later than ninety (90) days following the Participant’s Termination, subject to any delay required by
Section 5.7. If the participant elected installments for an In-Service Account and the installments commenced prior to Termination of employment, the remaining installments will be paid as scheduled. 

 

	 	b)	Form of Payment. The form of benefit payment from the In-Service Account shall be that form selected by the Participant pursuant to Section 5.7, below, except that if the Participant Terminates employment with the
Company prior to the date so specified, then the In-Service Account shall be paid in the same form applicable to the payment of the Retirement Account. If the Form of Payment selected provides for installments, such installments shall be made on or
about the anniversary of the initial payment. 

  

	 	c)	Change of Time and/or Form of Payment. The Participant may subsequently amend the form of payment or the intended date of payment to a date later than that date of payment in force immediately prior to the filing of
such request, by filing such amendment with the Committee no later than twelve (12) months prior to the current date of payment. The Participant may file this amendment, provided that each amendment must provide for a payout as otherwise
permitted under this paragraph at a date no earlier than five (5) years after the date of payment in force immediately prior to the filing of such request, and the amendment may not take effect for twelve (12) months after the request is
made. For purposes of this Article, a payment of amounts under this Plan, including the payment of annual installments over a number of years, shall be treated as a single payment, as provided in Treas. Reg. §1-409A-2(b)(2)(iii).

  

	5.4.	Death Benefit. Upon the death of a Participant prior to the commencement of distributions under this Plan from any particular Account, the Company shall pay to the Beneficiary an amount equal to the vested
Account balance in that Account in the form of a lump sum payment as soon as administratively possible. In the event of the death of the Participant after the commencement of distributions under this Plan from any Account, the benefits from that
Account(s) shall be paid to the Beneficiary from that Account in the form of a lump sum payment as soon as administratively possible. 

  

	5.5.	Disability Benefit. Upon the Termination of Participant’s employment with the Company after the determination of Disability and prior to the commencement of distributions under this Plan from any
particular Account, the Company shall pay to the Participant an amount equal to the vested Account balance in that Account in the form of a lump sum payment as soon as administratively practicable after the Termination date. In the event of the
Termination of Participant’s employment with the Company after the determination of Disability and after the commencement of distributions under this Plan from any Account, the benefits from that Account(s) shall be paid to the Participant from
that Account in the form of a lump sum payment as soon as administratively practicable. 

  

	5.6.	 Hardship Distributions. Upon a finding that a Participant has suffered a Financial Hardship, the
Committee may, in its sole discretion, terminate the existing Deferral 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 11

	 	
Commitment, and/or make distributions from any or all of the Participant’s Accounts. The amount of such distribution shall be limited to the amount reasonably necessary to meet the
Participant’s needs resulting from the Financial Hardship plus amounts necessary to pay taxes reasonably anticipated as a result of the distribution, after taking into account the extent to which such Financial Hardship is or may be relieved
through the reimbursement or compensation by insurance, or otherwise or by liquidation of the Participant’s assets (to the extent that liquidation of such assets would not itself cause Financial Hardship). The amount of such distribution will
not exceed the Participant’s vested Account balances. If payment is made due to Financial Hardship, the Participant’s deferrals under this Plan shall cease for the period of the Financial Hardship and for twelve (12) months
thereafter. If the Participant is again eligible to participate, any resumption of the Participant’s deferrals under the Plan after such twelve (12) month period shall be made only at the election of the Participant in accordance with
Article III herein. 

  

	5.7.	Payment to Specified Employees. Notwithstanding anything else to the contrary, payments of benefits from the Retirement Account, the Company Contribution Account and benefits payable from an In-Service
Account caused by the Termination of employment (other than by reason of death) of a Participant who is a Specified Employee at the time of Termination shall be payable as otherwise provided, except that the initial payment shall be delayed until
the first day of the seventh (7th) month following the Participant’s Termination of employment with the Company. 

  

	5.8.	Form of Payment. Unless otherwise specified in this Article, the benefits payable from any Account under this Plan shall be paid in the form of benefit as provided below, and specified by the Participant
in the Distribution Election applicable to that Account at the time of the initial deferral or credit to that Account. The permitted forms of benefit payments are: 

 

	 	a)	A lump sum amount which is equal to the vested Account balance; and 

  

	 	b)	Annual installments for a period of up to five (5) years where the annual payment shall be equal to the balance of the Account immediately prior to the payment, multiplied by a fraction, the numerator of which is
one (1) and the denominator of which commences at the number of annual payments initially chosen and is reduced by one (1) in each succeeding year. Interest on the unpaid balance shall continue to accrue. 

Notwithstanding the above, in the event of a Participant’s Termination without Cause, the Participant’s vested Account(s) shall be
distributed as soon as practicable following the Termination date, but no later than ninety (90) days following the Termination date. 
  

	5.9.	 Small Account. If a Participant’s vested, unpaid Company Contribution Account balance, as of
the time payments are to commence from the Company Contribution Account, is less than $50,000, the remaining unpaid, vested Company Contribution Account shall be paid in a lump sum, notwithstanding any election by the Participant to the contrary; if
the Participant’s vested, unpaid Retirement Account balance as of the 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 12

	 	
time payments are to commence from the Retirement Account is less than $50,000, the remaining unpaid, vested Retirement Account shall be paid in a lump sum, notwithstanding any election by the
Participant to the contrary; and, if the Participant’s vested, unpaid In-Service Account balance as of the time payments are to commence from such In-Service Account is less than $25,000, the remaining unpaid, vested In-Service Account shall be
paid in a lump sum, notwithstanding any election by the Participant to the contrary. 

  

	5.10.	Withholding; Payroll Taxes. The Company shall withhold from any payment made pursuant to this Plan any taxes required to be withheld from such payments under local, state or federal law. A Beneficiary,
however, may elect not to have withholding of federal income tax pursuant to Section 3405(a)(2) of the Code, or any successor provision thereto. 

  

	5.11.	Payments in Connection with a Domestic Relations Order. Notwithstanding anything to the contrary, the Company may make distributions to someone other than the Participant if such payment is necessary to
comply with a domestic relations order, as defined in Section 414(p)(1)(B) of the Code, involving the Participant. Where the domestic relations order permits discretion to request a distribution from the Participant’s Account(s) on the
part of the non-Participant spouse and such discretion has not been exercised, the Company shall distribute to the non-Participant spouse the amounts subject to the order as soon as practicable. 

 

	5.12.	Payment to Guardian. If a Plan benefit is payable to a minor, a person declared incompetent or to a person incapable of handling the disposition of the property, the Committee may direct payment to
the guardian, legal representative or person having the care and custody of such minor, incompetent or person. The Committee may require proof of incompetency, minority, incapacity or guardianship as it may deem appropriate prior to such
distribution. Such distribution shall completely discharge the Committee and the Company from all liability with respect to such benefit. 

  

	5.13.	Effect of Payment. The full payment of the applicable benefit under this Article V shall completely discharge all obligations on the part of the Company to the Participant (and the Participant’s
Beneficiary) with respect to the operation of this Plan, and the Participant’s (and Beneficiary’s) rights under this Plan shall cease. 

ARTICLE VI- BENEFICIARY DESIGNATION 
  

	6.1.	Beneficiary Designation. Each Participant shall have the right, at any time, to designate one (1) or more persons or an entity as Beneficiary to whom benefits under this Plan shall be paid in the
event of Participant’s death prior to complete distribution of the Participant’s vested Account balance. Each Beneficiary designation shall be in a written form prescribed by the Committee and shall be effective only when filed with the
Committee during the Participant’s lifetime. 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 13

	6.2.	Changing Beneficiary. Any Beneficiary designation may be changed by a Participant without the consent of the previously named Beneficiary by the filing of a new Beneficiary designation with the Committee.

  

	6.3.	No Beneficiary Designation. If any Participant fails to designate a Beneficiary in the manner provided above, if the designation is void, or if the Beneficiary designated by a deceased Participant dies
before the Participant or before complete distribution of the Participant’s benefits, the Participant’s Beneficiary shall be the Participant’s estate. 

 

	6.4.	Effect of Payment. Payment to the Beneficiary shall completely discharge the Company’s obligations under this Plan. 

ARTICLE VII- ADMINISTRATION 
  

	7.1.	Committee; Duties. This Plan shall be administered by the Committee, which shall consist of those individuals named by the Company, except in the event of a Change in Control as provided in
Section 7.5 below. The Committee shall have the authority to make, amend, interpret and enforce all appropriate rules and regulations for the administration of the Plan and decide or resolve any and all questions, including interpretations of
the Plan, as they may arise in such administration. A majority vote of the Committee members shall control any decision. Members of the Committee may be Participants under this Plan. 

 

	7.2.	Compliance with Section 409A of the Code. It is intended that the Plan comply with the provisions of Section 409A of the Code, so as to prevent the inclusion in gross income of any amounts
deferred hereunder in a taxable year that is prior to the taxable year or years in which such amounts would otherwise actually be paid or made available to Participants or Beneficiaries. This Plan shall be construed, administered, and governed in a
manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent. Although the Committee shall use its best efforts to avoid the imposition of taxation, interest and penalties under
Section 409A of the Code, the tax treatment of deferrals under this Plan is not warranted or guaranteed. Neither the Company, the GP, the Board, any director, officer, employee and advisor, nor the Committee (nor its designee) shall be held
liable for any taxes, interest, penalties or other monetary amounts owed by any Participant, Beneficiary or other taxpayer as a result of the Plan. For purposes of the Plan, the phrase “permitted by Section 409A of the Code,” or words
or phrases of similar import, shall mean that the event or circumstance shall only be permitted to the extent it would not cause an amount deferred or payable under the Plan to be includible in the gross income of a Participant or Beneficiary, or
cause the imposition of the additional tax, under Section 409A(a)(1) of the Code. 

  

	7.3.	Agents. The Committee may, from time to time, employ agents and delegate to them such administrative duties as it sees fit, and may from time to time consult with counsel who may be counsel to the Company
and/or the GP. 

  

	7.4.	Binding Effect of Decisions. The decision or action of the Committee with respect to any question arising out of or in connection with the administration, interpretation and application of the Plan and the
rules and regulations promulgated hereunder shall be final, conclusive and binding upon all persons having any interest in the Plan. 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 14

	7.5.	Indemnity of Committee. The Company shall indemnify and hold harmless the members of the Committee against any and all claims, loss, damage, expense or liability arising from any action or failure to act
with respect to this Plan on account of such member’s service on the Committee, except in the case of gross negligence or willful misconduct. 

  

	7.6.	Election of Committee After Change in Control. After a Change in Control, vacancies on the Committee shall be filled by majority vote of the remaining Committee members and Committee members may be removed
only by such a vote. If no Committee members remain, a new Committee shall be appointed by the compensation committee of the board of directors of the Company or its successor. 

ARTICLE VIII- CLAIMS PROCEDURE 
  

	8.1.	Claim. Any person or entity claiming a benefit, requesting an interpretation or ruling under the Plan (hereinafter referred to as “Claimant”), or requesting information under the Plan shall
present the request in writing to the Committee, which shall respond in writing as soon as practicable, but in no event later than ninety (90) days after receiving the initial claim (or no later than forty-five (45) days after receiving
the initial claim regarding a Disability under this Plan). 

  

	8.2.	Denial of Claim. If the claim or request is denied, the written notice of denial shall state: 

  

	 	a)	The reasons for denial, with specific reference to the Plan provisions on which the denial is based; 

  

	 	b)	A description of any additional material or information required and an explanation of why it is necessary, in which event the time frames listed in section 8.1 shall be one hundred and eighty (180) and
seventy-five (75) days from the date of the initial claim respectively; and 

  

	 	c)	An explanation of the Plan’s claim review procedure. 

  

	8.3.	Review of Claim. Any Claimant whose claim or request is denied or who has not received a response within sixty (60) days (or one hundred and eighty (180) days in the event of a claim regarding a
Disability) may request a review by notice given in writing to the Committee. Such request must be made within sixty (60) days (or one hundred and eighty (180) days in the event of a claim regarding a Disability) after receipt by the
Claimant of the written notice of denial, or in the event Claimant has not received a response sixty (60) days (or one hundred and eighty (180) days in the event of a claim regarding a Disability) after receipt by the Committee of
Claimant’s claim or request. The claim or request shall be reviewed by the Committee which may, but shall not be required to, grant the Claimant a hearing. On review, the claimant may have representation, examine pertinent documents, and submit
issues and comments in writing. 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 15

	8.4.	Final Decision. The decision on review shall normally be made within sixty (60) days (or forty-five (45) days in the event of a claim regarding a Disability) after the Committee’s receipt of
claimant’s claim or request. If an extension of time is required for a hearing or other special circumstances, the Claimant shall be notified and the time limit shall be one hundred twenty (120) days (or ninety (90) days in the event
of a claim regarding a Disability). The decision shall be in writing and shall state the reasons and the relevant Plan provisions. All decisions on review shall be final and bind all parties concerned. 

ARTICLE IX- AMENDMENT AND TERMINATION OF PLAN 
  

	9.1.	Amendment. The Company may at any time amend the Plan by written instrument, notice of which is given to all Participants and to Beneficiaries receiving installment payments, except that no amendment shall
reduce the amount vested or accrued in any Account as of the date the amendment is adopted. 

  

	9.2.	Company’s Right to Terminate. The Company may, in its sole discretion, terminate the entire Plan, or terminate a portion of the Plan that is identified as an elective account balance plan as
defined in Treas. Reg. §1.409A-1(c)(2)(i)(A), or as a nonelective account balance plan as defined in Treas. Reg. §1.409A-1(c)(2)(i)(B), and require distribution of all benefits due under the Plan or portion thereof, provided that:

  

	 	a)	The termination of the Plan does not occur proximate to a downturn in the financial health, as determined by the Committee, of the Company; 

 

	 	b)	The Company also terminates all other plans or arrangements which are considered to be of a similar type as defined in Treas. Reg. §1.409A -1(c)(2)(i), or as otherwise provided by the Code, as the portion of the
Plan which has been terminated; 

  

	 	c)	No payments made in connection with the termination of the Plan occur earlier than twelve (12) months following the Plan termination date other than payments the Plan would have made irrespective of Plan
termination; 

  

	 	d)	All payments made in connection with the termination of the Plan are completed within twenty-four (24) months following the Plan termination date; 

 

	 	e)	The Company does not establish a new plan of a similar type as defined in Treas. Reg. §1.409A-1(c)(2)(i), within three (3) years following the Plan termination date of the portion of the Plan which has been
terminated; and, 

  

	 	f)	The Company meets any other requirements deemed necessary to comply with provisions of the Code and applicable regulations which permit the acceleration of the time and form of payment made in connection with plan
terminations and liquidations. 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 16

 ARTICLE X-TREATMENT OF DIRECTORS 

 

	10.1.	Separate Plans; Service Recipient. The GP shall be deemed to establish a separate nonqualified deferred compensation plan for the members of the Board under the terms of the Plan. For purposes of the
separate plan established for the directors, any provision in the Plan referring to the “Company” shall be deemed to refer to the “GP” with respect to the participation of the directors on the Board. With respect to directors who
are Participants in the Plan, the “service recipient” for purposes of Section 409A of the Code shall be the GP and any reference contained in the Plan to an “employer” shall be to the GP and not the Company. Any
determination of “service recipient” shall be made in a manner consistent with the Participant’s status as an employee or director when an amount is credited under the Plan’s terms with respect to such status. 

 

	10.2.	Deferral Commitments. With respect to directors who are participants in the Plan, any Deferral Commitment made pursuant to Article III shall be made with respect to Compensation received from the GP and any
reference to the “Company” shall be read as a reference to the “GP”. Notwithstanding the foregoing, if a director of the Board is also an employee of the Company, then such individual’s participation in the Plan shall be
determined separately as to Compensation earned as a director and that earned as an employee, and such individual shall file separate Deferral Commitment forms for each such form of Compensation. 

 

	10.3.	Employer Contributions. With respect to directors who are Participants in the Plan, the only type of employer contributions available under the Plan shall be Discretionary Contributions. Notwithstanding
the foregoing, if a director of the Board is also an employee of the Company, then the available employer contributions under the Plan shall be determined separately as to Compensation earned as a director and that as an employee (i.e., Matching
Contributions and Discretionary Contributions would be available for Compensation earned as an employee, but only Discretionary Contributions would be available for Compensation earned as a director). 

ARTICLE XI-MISCELLANEOUS 
  

	11.1.	Unfunded Plan. This Plan is an unfunded plan maintained primarily to provide deferred compensation benefits for a select group of “management or highly-compensated employees” within the meaning
of Sections 201, 301, and 401 of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), and therefore is exempt from the provisions of Parts 2, 3 and 4 of Title I of ERISA. 

 

	11.2.	Unsecured General Creditor. Notwithstanding any other provision of this Plan, Participants and Beneficiaries shall be unsecured general creditors, with no secured or preferential rights to any assets of
the Company or any other party for payment of benefits under this Plan. Any property held by the Company for the purpose of generating the cash flow for benefit payments shall remain its general, unpledged and unrestricted assets. The Company’s
obligation under the Plan shall be an unfunded and unsecured promise to pay money in the future. 

  

	11.3.	 Trust Fund. The Company shall be responsible for the payment of all benefits provided under the
Plan. In its sole discretion, the Company may establish one (1) or more trusts, 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 17

	 	
with such trustees as the Board may approve, for the purpose of assisting in the payment of such benefits. The assets of any such trust shall be held for payment of all the Company’s general
creditors in the event of insolvency. To the extent any benefits provided under the Plan are paid from any such trust, the Company shall have no further obligation to pay them. If not paid from the trust, such benefits shall remain the obligation of
the Company. 

  

	11.4.	Nonassignability. Neither a Participant nor any other person shall have any right to commute, sell, assign, transfer, pledge, anticipate, mortgage or otherwise encumber, transfer, hypothecate or convey in
advance of actual receipt the amounts, if any, payable hereunder, or any part thereof, which are, and all rights to which are, expressly declared to be unassignable and non-transferable. Except with respect to payments pursuant to domestic relations
orders as described in Section 5.10, above, no part of the amounts payable shall, prior to actual payment, be subject to seizure or sequestration for the payment of any debts, judgements, alimony or separate maintenance owed by a Participant or
any other person, nor be transferable by operation of law in the event of a Participant’s or any other person’s bankruptcy or insolvency. 

  

	11.5.	Not a Contract of Employment. This Plan shall not constitute a contract of employment between the Company and the Participant. Nothing in this Plan shall give a Participant the right to be retained in the
service of the Company or to interfere with the right of the Company to discipline or discharge a Participant at any time. 

  

	11.6.	Protective Provisions. A Participant will cooperate with the Company by furnishing any and all information requested by the Company, in order to facilitate the payment of benefits hereunder, and by taking
such physical examinations as the Company may deem necessary and taking such other action as may be requested by the Company. 

  

	11.7.	Governing Law. The provisions of this Plan shall be construed and interpreted according to the laws of the State of Texas, except as preempted by federal law. 

 

	11.8.	Validity. If any provision of this Plan shall be held illegal or invalid for any reason, said illegality or invalidity shall not affect the remaining parts hereof, but this Plan shall be construed and
enforced as if such illegal and invalid provision had never been inserted herein. 

  

	11.9.	Notice. Any notice required or permitted under the Plan shall be sufficient if in writing and hand delivered or sent by registered or certified mail. Such notice shall be deemed given as of the date of
delivery or, if delivery is made by mail, as of the date shown on the postmark on the receipt for registration or certification. Mailed notice to the Committee shall be directed to the Company’s corporate office. Mailed notice to a Participant
or Beneficiary shall be directed to the individual’s last known address in the Company’s records. 

  

	11.10.	Successors. The provisions of this Plan shall bind and inure to the benefit of the Company and its successors and assigns. The term successors as used herein shall include any corporate or other business
entity which shall, whether by merger, consolidation, purchase or otherwise acquire all or substantially all of the business and assets of the Company, and successors of any such corporation or other business entity. 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 18

 CRESTWOOD EQUITY PARTNERS LP 

BY: 
 DATED: 

CRESTWOOD EQUITY GP LLC 
 BY: 

DATED: 

  

			
	NONQUALIFIED DEFERRED COMPENSATION PLAN	  	PAGE 19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}]]